Werle Isabel, Nascimento Laura M M, Dos Santos Aymee L A, Soares Luciane A, Dos Santos Rafael G, Hallak Jaime E C, Bertoglio Leandro J
Departamento de Farmacologia, Universidade Federal de Santa Catarina, Florianópolis, Santa Catarina, Brazil.
Departamento de Neurociências e Comportamento, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil.
Br J Pharmacol. 2024 Jun;181(11):1671-1689. doi: 10.1111/bph.16315. Epub 2024 Feb 6.
Ayahuasca (AYA) is a botanical psychedelic with promising results in observational and small clinical trials for depression, trauma and drug use disorders. Its psychoactive effects primarily stem from N,N-dimethyltryptamine (DMT). However, there is a lack of research on how and where AYA acts in the brain. This study addressed these questions by examining the extinction of aversive memories in AYA-treated rats.
We focused on the 5-HT and 5-HT receptors, as DMT exhibits a high affinity for both of them, along with the infralimbic cortex in which activity and plasticity play crucial roles in regulating the mnemonic process under analysis.
A single oral treatment with AYA containing 0.3 mg·kg of DMT increased the within-session extinction of contextual freezing behaviour without affecting its recall. This protocol, when repeated twice on consecutive days, enhanced extinction recall. These effects were consistent for both 1- and 21-day-old memories in males and females. AYA effects on fear extinction were independent of changes in anxiety and general exploratory activity: AYA- and vehicle-treated animals showed no differences when tested in the elevated plus-maze. The 5-HT receptor antagonist MDL-11,939 and the 5-HT receptor antagonist WAY-100635 infused into the infralimbic cortex respectively blocked within- and between-session fear extinction effects resulting from repeated oral administration of AYA.
Our findings highlight complementary mechanisms by which AYA facilitates the behavioural suppression of aversive memories in the rat infralimbic cortex. These results suggest potential beneficial effects of AYA or DMT in stress-related disorders.
阿亚瓦斯卡(AYA)是一种植物性致幻剂,在抑郁症、创伤和药物使用障碍的观察性研究及小型临床试验中显示出有前景的结果。其精神活性作用主要源于N,N - 二甲基色胺(DMT)。然而,关于AYA在大脑中的作用方式和作用部位的研究尚缺。本研究通过检测经AYA处理的大鼠厌恶记忆的消退来解决这些问题。
我们聚焦于5 - 羟色胺(5 - HT)及其受体,因为DMT对它们二者均表现出高亲和力,同时也关注了内嗅皮质,其活性和可塑性在调节所分析的记忆过程中起着关键作用。
单次口服含0.3mg·kg DMT的AYA可增加情境性僵住行为在实验过程中的消退,而不影响其回忆。该方案连续两天重复两次可增强消退回忆。这些效应在雄性和雌性大鼠的1日龄和21日龄记忆中均一致。AYA对恐惧消退的作用独立于焦虑和一般探索活动的变化:在高架十字迷宫测试中,经AYA处理和经赋形剂处理的动物无差异。分别注入内嗅皮质的5 - HT受体拮抗剂MDL - 11,939和5 - HT受体拮抗剂WAY - 100635分别阻断了重复口服AYA导致的实验过程内和实验过程间的恐惧消退效应。
我们的研究结果突出了AYA促进大鼠内嗅皮质对厌恶记忆进行行为抑制的互补机制。这些结果提示AYA或DMT在应激相关障碍中可能具有有益作用。